Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 20:30 ET | Source: InnoCare Pharma

InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China

ICP-B794 has demonstrated superior anti-tumor activity in animal models, and exhibited significant tumor-killing effects even in large tumors.
October 30, 2025 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of...
October 29, 2025 16:43 ET | Source: Fight Colorectal Cancer

Excitement surges as nonprofits, public safety departments, and hairy enthusiasts gear up for No Shave November

Springfield, Mo., Oct. 29, 2025 (GLOBE NEWSWIRE) -- No Shave November, one of the nation’s largest cancer awareness movements, returns with a refreshed look and a $250,000 goal to fight cancer. ...
October 29, 2025 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025

REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...
October 29, 2025 10:00 ET | Source: Dewpoint Therapeutics

FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

Dewpoint's DPTX3186 receives FDA Orphan Drug Designation for gastric cancer - the first ever granted to a condensate-modulating therapeutic.
October 28, 2025 07:44 ET | Source: Crosetto Foundation for the Reduction of Cancer Deaths

Evidence Against Evidence: CERN-IEEE FPGA vs. Crosetto 3D-Flow, a Breakthrough Invention Recognized 32 Years Ago That Could Have, and Can Still, Save Billions of Euros and Millions of Lives

32 Years of Suppression and Ongoing Barriers to Transparency. A Call for responsibility to address and resolve contradictions in science
October 27, 2025 07:00 ET | Source: EDAP TMS S.A.

EDAP to Participate in the UBS Global Healthcare Conference

EDAP to Participate in the UBS Global Healthcare Conference Company to Host 1x1 Investor Meetings on Monday, November 10th, 2025 AUSTIN, Texas, October 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
October 27, 2025 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of...
October 24, 2025 04:00 ET | Source: GENENTA SCIENCE SPA

Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

GENENTA AND ANEMOCYTE ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE OFF-THE-SHELF LVV PLASMID DNA PRODUCTION
October 23, 2025 10:01 ET | Source: Imunon, Inc.

IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in...